Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04336852 · ClinicalTrials.gov registry record · NA
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04336852: Clinical Trial NA study, sponsored by University of Illinois at Chicago.
NCT04336852 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04336852, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this study is to develop a test of cerebral vessel function by inducing a reactive hyperemia that will elicit a rapid and profound increase in cerebral vessel shear stress. The results of this project may lead to development of a test with prognostic/predictive utility for individual risk assessment of a future cerebrovascular event/disease. This information will be of vital importance to the medical community in regards to cerebrovascular health in aging individuals, and testing of interventions and therapies that may ameliorate these effects.
Primary Outcome
Assessment of internal carotid artery dilation and blood flow in response to a reactive hyperemic stimulus
Interventions
- PROCEDURE Flow mediated dilation (brachial and femoral arteries)
- PROCEDURE Cerebral vascular reactivity to carbon dioxide (CO2)
- PROCEDURE Cerebral vascular function test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2023-05-12 |
| Phase | NA |
Why NCT04336852 stopped before completion
NCT04336852 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Flow mediated dilation (brachial and femoral arteries) is the first listed.
NCT04336852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04336852 about?
NCT04336852 is a clinical study titled "Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function". The goal of this study is to develop a test of cerebral vessel function by inducing a reactive hyperemia that will elicit a rapid and profound increase in cerebral vessel shear stress. The results of this project may lead to development of a test with prognostic/predictive utility for individual ris...
What is the current status of trial NCT04336852?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-09-14. Estimated completion is 2023-05-12.
What interventions are being tested in trial NCT04336852?
The interventions under investigation include: Flow mediated dilation (brachial and femoral arteries) (PROCEDURE), Cerebral vascular reactivity to carbon dioxide (CO2) (PROCEDURE), Cerebral vascular function test (PROCEDURE).
Who is sponsoring clinical trial NCT04336852?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04336852's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI